The Global Evidence Summit, taking place September 13 – 17, 2017 in Cape Town, South Africa, will highlight how evidence can be used to inform policy and practice. GloPID-R members Research Council of Norway, South African Medical Research Council (SAMRC), and Wellcome Trust will be participating at this premier event in evidence-based policy.
The summit is organized into five plenary sessions each with a particular focus promoting evidence- based approaches. In the realm of working together to fight infectious diseases, there is Plenary 3 “Evidence for Emerging Crises: How international collaboration and innovation can solve global humanitarian crises, such as Ebola.”
The keynote speakers will use the example of the Ebola outbreak to present on the impact of evidence on populations, the global response, the Coalition for Epidemic Preparedness Innovations (CEPI), and building infrastructure for the future.
Breakout sessions will follow each plenary to continue the exchange of ideas. GloPID-R’s Data Sharing Working Group Chair, Katherine Littler, and SAMRC’s Richard Gordon will be panelists on “Impact and Evaluation of Research: Perspectives from Funders and Users of Research.” Panelists will share how funders measure the impact of research, the role of funded research in developing evidence for decision making, and current impact and evaluation methods.
“There is strength in numbers. When funders work together to share research, data, and information and to promote networks, this accelerates knowledge transfer- directly impacting those who need it most.”
Multiple organizations have joined forces to host this summit: Cochrane, The Campbell Collaboration, Guidelines-International Network, International Society for Evidence-based Health Care, and Joanna Briggs Institute. Cochrane South Africa is a research unit of the South African Medical Research Council (SAMRC). It receives its core funding from the SAMRC and raises project-specific grants from external funders in collaboration with partners.